Edgewise Therapeutics Inc... (EWTX)

NASDAQ: EWTX · Real-Time Price · USD

16.71

0.31 (1.89%)

At close: May 01, 2025, 3:59 PM

17.10

2.33%

Pre-market: May 02, 2025, 08:27 AM EDT

Edgewise Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-133.81M	-100.16M	-67.64M	-42.81M	-17.12M	-9.71M
Depreciation & Amortization	2.29M	1.73M	538K	272K	185K	123K
Stock-Based Compensation	24.71M	17.56M	10.92M	4.4M	354K	77K
Other Working Capital	8.59M	-1.47M	4.04M	1.98M	1.43M	59K
Other Non-Cash Items	-12.54M	-9.52M	-543K	2.29M	203K	48K
Deferred Income Tax	n/a	n/a	n/a	-2.29M	-203K	-48K
Change in Working Capital	10.33M	-1.56M	4.09M	4.63M	1.95M	334K
Operating Cash Flow	-109.03M	-91.95M	-52.63M	-33.51M	-14.63M	-9.17M
Capital Expenditures	-1.31M	-5.75M	-5.55M	-668K	-203K	-180K
Cash Acquisitions	n/a	n/a	65.03K	241.56K	n/a	n/a
Purchase of Investments	-477.06M	-255.87M	-292.39M	-288.2M	-24.18M	n/a
Sales Maturities Of Investments	293.71M	364.5M	227.36M	46.64M	n/a	n/a
Other Investing Acitivies	n/a	n/a	-65.03K	-241.56K	-24.18K	n/a
Investing Cash Flow	-184.66M	102.89M	-70.58M	-242.23M	-24.38M	-180K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	10.11M	548K	474K	236K	202K	22K
Financial Cash Flow	249.25M	53.17M	129.64M	186.38M	120.28M	24.8M
Net Cash Flow	-44.43M	64.1M	6.43M	-89.35M	81.26M	15.45M
Free Cash Flow	-110.34M	-97.69M	-58.18M	-34.17M	-14.84M	-9.35M